Open Nav
2018 Participating Investors

Below is a representative list of participating investors for the 2018 CEO & Investor Conference:

4c Advisors
A C Binder Corp
Abbvie Ventures
Aceras Life Sciences
Acuris Partners
Adamas Healthcare Fund
Aegis Capital Corp
Aeon Life Science Fund
Agent Capital
Agilent Technologies
Aisling Capital
Aleph Capital
Alexandria Capital
Alignment Ventures
Allied Minds
Ally Bridge Group
Alpine Equity Advisors
Altaris Capital Partners
Altitude Life Science Ventures
Ameritech Advisors
Amzak Health
Anson Funds
Apple Tree Partners
ARCH Venture Partners
Archer Avenue Partners
Arcus Ventures
Aristar Capital
Arix Bioscience
Arjava Capital Group
Asahi Kasei America
Ashford Capital Management
Aspire Capital Partners
ATEL Ventures
ATEM Capital
Athena Bio Ventures
Atheneos Capital
Athyrium Capital Management
AuGC BioFund
Aurora Asset Research
B. Riley FBR
Bank of America Merrill Lynch
Bank Of America, Healthcare Group
Bentley Associates
Bifrost Capital
Bigger Capital Fund
Biondo Investment Advisors
Biosense Global 
Biosphere Capital Ventures
Biotech Alliances International
Biotech Investment Group
Black Diamond Advisors
Blue Rock Capital Advisors
BMO Capital
Bohe Angel Fund
Bojian Capital
Boxer Capital
Brace Pharma Capital
Brace Pharmaceuticals
Bridgebio Pharma
Brock Capital
Brookline Capital Markets
Cabot Capital Group
CAM Capital
CANA Partners
Capital IP
Cato BioVentures
C-Bridge Capital
CEC Capital
Cedrus Investments
Chardan Capital Markets
Charlestown Capital Advisors
CHC Ventures
Chia Tai Tianqing Pharmaceutical Group
Church Pension Fund
CL Investment Group
Columbus Circle Corporate
Craig Drill Capital
Crescent Capital Ventures
Cross Current Research
CS McKee
CSC Leasing
CTI Life Sciences
Dabar Investment Associatees
Daniloff Capital
DB Capital
Dec Family Ventures
Deerfield Management
Discover Fund
DoubleRock LLC
Douglas C. Lane & Associates
DTB Capital Management
Dynamk Capital
Easton Capital
Efrat Investments
EGB Ventures
Ensign Peak Advisors
Enso Ventures
Esousa Holdings
Evepine Capital
Excelyrate Capital
FC Capital Management
Federated Kaufmann Fund
Ferghana Partners
Fidelity Investments
Fineman Financial
First Island Capital
First Republic Investment Management
First Seafront Fund Management
Flagship Pioneering
Fortress Biotech
Gagnon Securities
GCF Family Office
GE Ventures
GHS Investments
Global Source Ventures
GMP Securities
GMX Capital Partners
Golden Seeds
Good Health Capital
Grant Engine
GreenSky Capital
Grey Sky Venture Partners
Griffin Securities
Guggenheim Partners
Guggenheim Securities
H.C. Wainwright & Co.
Hartford Financial Management
Hayfin Capital Management
Health Passion Fund
Helix Management
Hercules Capital
Hirst Shabian & Hirst Investment Services
Horizon Technology Finance
Horizons Ventures
Hudson Bay
Hudson East Capital
Humanwell Healthcare Group
Illumina Ventures
Ingalls & Snyder
inThought Research
Intuitive Venture Partners
Inukshuk Capital
Invemed Associates
IRC Securities/Strategy Signal
Issar Therapeutics
J. Goldman & Co. 
J.P. Morgan
Janney Montgomery Scott
JBS Healthcare Ventures
JGB Capital
Jina Ventures
JMP Securities
Johnson & Johnson Innovation - JJDC
Johnston Associates
Kairos Ventures
Kalka Fund
Karthala Capital Management 
Katalyst Securities
Katz Associates
KESA Partners
Kingdon Capital
Knoll Capital Management
Knott Partners
L1 Capital Global
L2 Capital
Ladenburg Thalmann
Laidlaw and Company
Landmark Angels/ Landmark Family Office
Lazard Asset Management
Leviticus Partners, L.P.
Lexington Capital Management
Life Sciences Alternative Funding
LifeScience EquityPartners


LifeTech Capital
Lincoln Park Capital
Little Gem Life Science Partners
Locust Walk Capital
Lone Pine Associates
Longitude Capital
Lumira Capital
LYFE Capital
M Ventures
Madison Square Capital 
Manatuck Hill Partners
Marathon Asset Management
Mass Innovation Labs
Maxim Group
Maytech Global Investments
Maz Capital Advisors
Medex Capital
MedPro Investors
Medpro Investors 
Mentor Capital Partners
Meyers Investments Family
Micro Cap Asset Management
Mid Atlantic Bio Angels (MABA)
Militia Hill Ventures
Mizuho Corporate Bank
Mizuho Securities
Montrose Capital Partners
Moose Hill Asset Management
Morgan Stanley
Morgens, Waterfall, Vintiadis & Co. 
Mossrock Capital
MP Healthcare Venture Management
MSF Capital Advisors
Murdock Capital Partners
Murray Capital Group
MV Corp Services
MVM Partners
MVP Capital Partners
NauVista Capital Management
Needham & Company
Needham and Company
New Enterprise Associates
New Harbor Venture Partners
New Jersey Division of Investment
New Science Global Healthcare Fund
New Science Ventures
New York International Capital
New York State Innovation Venture Capital Fund
New York Ventures
Nexus Life Science Partners
NF Trinity Capital
Noble Capital Markets
Noble Life Science Partners
Noble LifeSelect Fund
Nordcon Capital
Novatio Ventures
NYC Economic Development Corporation
Oberland Capital
Omega Funds
Opti Capital Management
Opto Capital Group
Opus Point Partners
OrbiMed Advisors
Orchard View Capital Advisors 
Otsuka America Pharmaceutical
Otsuka Pharmaceutical Development & Commercialization
Oxford Finance
Pappas Capital
Pappas Ventures
Park Ave Capital Management International
Paulson Investment
Paulson Investment Co.
Peak One Investments
Petrichor Healthcare Capital Management
Pharmakon Advisors
PHX Financial
Piper Jaffray & Co.
Pivotal BioVenture Partners
Point72 Asset Management, L.P.
Portola Capital Partners
Prevail Partners
Princeton BioPharma Capital Partners
Promethean Capital Group
Qilu Pharmaceutical
Raymond James
RBC Capital Markets
Red Hook Asset Management
Relentless Pursuit Partners
Remiges Ventures
Repertoire Asset Management
RHK Capital 
Rho Ventures
Robert W. Baird & Co.
Rockport Venture Fund
Rolin Capital
Roosevelt Investments
Roth Capital Partners
RTP Capital
S&A Investments
Sabby Management
Sagestone Capital / Elmwood Capital
Santen Ventures
Satter Management
SBP Management
SC Fundamental
Schonfeld Strategic Advisers
Schonfeld Strategic Advisors
Sea Otter Global Ventures
Seaport Global Securities
Second Line Capital Management
Serrado Capital
Shattemac Capital Management
Shaw Strategic Capital
Silicon Valley Bank
Silver Arrow Partners
SilverArc Capital
Sio Capital Management
Slater Technology Fund
Snyder Capital Management
Sorrento Therapuetics
Special Situations Funds
Sphera Healthcare Fund
Spouting Rock Asset Management
Sprim Ventures
Square 1 Bank
SR One
Stadnyk and Partners
Stanphyl Capital Management
SternAegis Ventures
Stifel Financial
Suntrust Robinson Humphrey
Surveyor Capital
Susquehanna International Group
Sutton Place Management
Symphonia Partners
Symphony Capital
Syzygy Therapeutics
TaiAn Technologies
Talfinium Investments
Tanaka Capital Management
Tang Capital Management
TAP Advisors
TCG Lifescience and Technology Fund
The Carlyle Group
The Leukemia & Lymphoma Society
Tosoh USA
Tralucent Asset Management
Transpacific Venture Capital Partners
Triple Gate Capital
Tryphon Capital
Turret Capital Management
Two Sigma Ventures
UNUM Capital
Valquest Capital Management
Varana Capital
Vector Capital
Versant Ventures
Vinart Corp Capital Management
Virtus Inspire Ventures
Vista Capital Advisors 
Vivo Capital
W Global Capital
WallachBeth Capital
WBB Securities
Weigao Group
Wellington Shields & Co.
WestPark Capital
William Blair & Co.
Windrose Health Investors
Wingate Capital Management
Wolf Capital Management
Wolfswood Partners
Xeraya Capital Life Venture
Yale University
YuanMing Capital
Zacks SCR
Zenith Capital


*as of 2/9/2018